In chronic myeloid leukemia (CML), STAP1 deficiency leads to impaired STAT5 activity, thereby downregulating the expression of anti-apoptotic genes such as Bcl-2 and Bcl-xL (42). Here, BCL2L1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.